Skyline Licenses TrovaGene Biomarker for AML

Skyline Diagnostics will use the NPM1 biomarker technology in a microarray testing service to stratify AML patients.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.